Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-fiscal-year-2023-financial-and-business-results-on-march-14-2024-302082682.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-participate-in-the-2024-bio-ceo--investor-conference-302069408.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-2024-letter-to-stockholders-302022312.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-third-quarter-2023-financial-and-business-results-301978381.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-third-quarter-2023-financial-and-business-results-on-november-6-2023-301971169.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-statement-regarding-security-situation-in-israel-301950666.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-appoints-eliot-richard-forster-phd-as-chairman-of-its-board-of-directors-301924305.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-present-at-the-hc-wainwright-25th-annual-global-investment-conference-301919041.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-second-quarter-2023-financial-and-business-results-301894457.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference-301890119.html